Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit |
|
abx092223-100l |
Abbexa |
100 µl |
EUR 650 |
Human IgG antibody Laboratories manufactures the anticancer monoclonal igm reagents distributed by Genprice. The Anticancer Monoclonal Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Anticancer products are available in stock. Specificity: Anticancer Category: Monoclonal Group: Igm
Human Phosphatidylinositol Antibody IgG/IgM (PIAb-IgG/IgM) ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Phosphatidylinositol Antibody IgG/IgM (PIAb-IgG/IgM) ELISA Kit |
|
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Phosphatidylinositol Antibody IgG/IgM (PIAb-IgG/IgM) ELISA Kit |
|
MyBiosource |
96-Strip-Wells |
EUR 765 |
Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit |
|
Abbexa |
100 µl |
EUR 650 |
Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit |
|
Abbexa |
1 ml |
EUR 7200 |
Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit |
|
Abbexa |
200 µl |
EUR 2100 |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
|
Shanghai Sunred Biological Technology |
96 tests |
EUR 528 |
|
|
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
|
GenAsia Biotech |
48T |
EUR 346.8 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
|
GenAsia Biotech |
48 Tests |
Ask for price |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
|
GenAsia Biotech |
96T |
EUR 559.2 |
Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit |
|
GenAsia Biotech |
96 Tests |
EUR 388 |
Igm information
Anticancer agent 110 |
|
HY-149805 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 110 is an anticancer agent with in vitro anticancer activity and excellent anti-leukemia potency. Anticancer agent 110 is highly cytotoxic to K-562 lineage chronic myelogenous leukemia cells at nanomolar concentrations. Anticancer agent 110 causes DNA damage and leads to apoptosis[1]. |
Anticancer agent 114 |
|
HY-149832 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 114 is a potent and orally active dipeptide boronic acid ester proteasome inhibitor with an IC50 value of 2.2 nM. Anticancer agent 114 has antiproliferative activity against the RPMI-8226 cells. Anticancer agent 114 can be used in research of multiple myeloma[1]. |
Anticancer agent 126 |
|
HY-149873 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 126 (compound 12) is a WDR5 inhibitor with anticancer effects. Anticancer agent 126 disrupts WDR5-MYC interaction in cells and reduce MYC target gene expression[1]. |
Anticancer agent 130 |
|
HY-149890 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 130 (compound 8d) is an anticancer agent that can significantly induce apoptosis in A549 cells[1]. |
Anticancer agent 98 |
|
HY-149920 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 98 (compound 12k) is a microtubule/tubulin-polymerization inhibitor (Kd=16.9 μM). Anticancer agent 98 exerts antiproliferative potency against tumor cells, exhibits anti-angiogenesis effect in vitro. Anticancer agent 98 exhibits good human and mouse liver microsomes stability with both t1/2>300 min[1]. |
Anticancer agent 105 |
|
HY-149949 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 105 is a compound based on thienopyrimidine scaffold, with with good safety and anticancer properties. Anticancer agent 105 shows selective toxicity towards melanoma cancer, and induces apoptosis. And Anticancer agent 105 significantly inhibits the metastatic nodules, even in pulmonary metastatic melanoma mouse model[1]. |
Anticancer agent 106 |
|
HY-149950 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 106 (compound 10ic) is an anticancer agent that induces apoptosis in B16-F10 melanoma cells. Anticancer agent 106 also potently inhibits metastatic nodules in a mouse model of lung metastatic melanoma. Anticancer agent 106 can be used in the study of cancer, especially lung metastatic melanoma[1]. |
Anticancer agent 107 |
|
HY-149951 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 107(Compd 11jc) has significant antitumor activity and can be used as an anticancer agent in the study of pulmonary metastatic melanoma[1]. |
Anticancer agent 111 |
|
HY-149977 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 111 (compound 11) is a potent cytochrome P450 inhibitor with an IC50 value of 3 μM for CYP3A4. Anticancer agent 111 has anticancer activity. Anticancer agent 111 can be used in research of cancer[1]. |
Anticancer agent 120 |
|
HY-149997 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 120 (compound 21) is an N-acylated ciprofloxacin derivative, which has certain antibacterial activity and induces ROS to promote cancer cell apoptosis[1]. |
Anticancer agent 76 |
|
HY-150571 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis[1]. |
Anticancer agent 9 |
|
HY-78884 |
MedChemExpress |
10 mg |
EUR 346.33 |
|
Description: Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1]. |
Anticancer agent 77 |
|
HY-151092 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 77 (Compound 6c) shows anticancer activity, and can be widely used in synthesis and medicinal chemistry research[1]. |
Anticancer agent 78 |
|
HY-151119 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 78 is a potent anticancer agent. Anticancer agent 78 shows cytotoxicity. Anticancer agent 78 exhibits anti-aromatase activity with an IC50 value of 0.9 µM. Anticancer agent 78 has the potential for the research of breast cancer[1]. |
Anticancer agent 79 |
|
HY-151120 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 79 (compound 3d) shows good anti-breast cancer activity. Anticancer agent 79 shows good cytotoxic activity in T47-D cells, with an IC50 of 13.64 ± 0.26 μM[1]. |
Anticancer agent 80 |
|
HY-151121 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 80 (Compound 3c) is an anticancer agent. Anticancer agent 80 exhibits the dark cytotoxicity against T47-D with IC50 of 10.14 µM[1]. |
Anticancer agent 81 |
|
HY-151207 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 81 (Compound 37b3) is an anticancer agent and can induce tumor cell cycle arrest and apoptosis. Anticancer agent 81 can be used as a payload to conjugate with Trastuzumab (HY-P9907) to obtain the antibody–agent conjugate (ADC) T-PBA. T-PBA maintained its mode of target and internalization ability of Trastuzumab[1]. |
Anticancer agent 83 |
|
HY-151426 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 83 is a potent anticancer agent, inhibits LOX IMVI cells growth with a GI50 value of 0.15 mM. Anticancer agent 83 reduces mitochondrial membrane potential and induces DNA damage to induces leukemia cells apoptosis[1]. |
Anticancer agent 84 |
|
HY-151471 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 84 is an anticancer agent. Anticancer agent 84 represses the transcription of c-MYC by stabilizing the G-quadruplex (G4) structure. Anticancer agent 84 can be used for the research of cancer[1]. |
Anticancer agent 85 |
|
HY-151564 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 85 (compound 6j) is an anticancer agent that shows good cytotoxicity against MCF7 cells. Anticancer agent 85 can be used in breast cancer and other cancer studies[1]. |
Anticancer agent 86 |
|
HY-151565 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 86 (compound 6i) shows potential activity against breast adenocarcinoma[1]. |
Anticancer agent 87 |
|
HY-151570 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 87 is a potent anticancer agent. Anticancer agent 87 can be used in the research of breast adenocarcinoma and liver cancer[1]. |
Anticancer agent 88 |
|
HY-151572 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 88 is a potent anticancer agent. Anticancer agent 88 can be used in the research of breast adenocarcinoma and liver cancer[1]. |
Anticancer agent 89 |
|
HY-151587 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 89 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity, has high inhibition against the three cell line from ovarian cancer (OVCAR-4), renal cancer (A498), and melanoma (SK-MEL-5)[1]. |
Anticancer agent 90 |
|
HY-151588 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 90 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity. Anticancer agent 90 has high inhibition against the two cell line from ovarian cancer (OVCAR-4), renal cancer (A498)[1]. |
Anticancer agent 91 |
|
HY-151592 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 91 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. Anticancer agent 91 has high inhibition against the two cell line from CNS cancer (SF-539 and SNB-75)[1]. |
Anticancer agent 92 |
|
HY-151888 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 92 (Compound 5f) is an anticancer agent that is nontoxic against noncancerous cells[1]. |
Anticancer agent 93 |
|
HY-152084 |
MedChemExpress |
Get quote |
Ask for price |
|
Description: Anticancer agent 93 is a 4-Hydroxycoumarin derivative. Anticancer agent 93 can inhibit invasion and migration of lung cancer cells by modulating expression of epithelial-mesenchymal transition (EMT) effectors[1]. |